Thank you for standing by and welcome to Hercules Capital Fourth Quarter and Full Year 2023 Financial Results Conference call. At this time, all participants are on a listen-only mode. After the speaker's presentations, there'll be a question-and-answer session. Please be advised that today's call is being recorded. I will now return the conference to your host, Mr. Michael Hara, Managing Director of Investor relations. Please go ahead.

Thank you, Valerie. Good afternoon, everyone, and welcome to Hercules conference call for the fourth quarter and full year 2023. With us on the call today from Hercules are Scott Bluestein, CEO and Chief Investment Officer, and Seth Meyer, CFO. Hercules financial results were released just after today's market close and can be accessed from Hercules' Investor Relations section at investor.htgc.com. An archive webcast replay will be available on the investor relations webpage for at least 30 days following the conference call. During this call, we may make forward-looking statements based on our own assumptions and current expectations. These forward-looking statements are not guarantees of future performance and should not be relied upon in making any investment decision. Actual financial results may differ from the forward-looking statements made during this call for a number of reasons, including but not limited to, the risks identified in our annual report on Form 10-K and other filings that are publicly available on the SEC's website. Any forward-looking statements made during this call are made only as of today's date and Hercules assumes no obligation to update any such statements in the future. And with that, I will turn the call over to Scott.

Thank you, Michael, and thank you all for joining the Hercules Capital Q4 and full year 2023 earnings call. Following our record operating performance in 2022, Hercules Capital once again raised the bar higher and delivered record performance in 2023. 2023 was a banner year for Hercules Capital, where we set several new financial and performance records, and I am incredibly proud of what our talented and growing team accomplished. Our record-setting performance in 2023 culminated with the strongest total and net investment income quarter in the company's history and the recent declaration of a new supplemental distribution program for our shareholders. Our performance in 2023 reflects the benefits of being able to operate an institutional venture and growth stage lending platform at scale, maintain robust liquidity and a strong balance sheet, and work with a best-in-class team with significant experience in this asset class. Thanks to the growth of both the BDC and our private credit funds business, Hercules Capital is now managing approximately $4.2 billion of assets, an increase of over 15% from where we were at year-end 2022. Despite ongoing market, macro, and geopolitical volatility, which impacted growth stage companies throughout 2023, the continued strength and expansion of our origination platform, robust liquidity position, and strong balance sheet put us in a position to deliver achievements on multiple fronts in 2023, including record full year 2023 total gross fundings of $1.6 billion, an increase of 9.1% year-over-year. Record full year 2023 total investment income of $460.7 million, an increase of 43.2% year-over-year. Record full year 2023 net investment income of $304 million, an increase of 61.7% year-over-year. Four consecutive years of delivering supplemental distributions to our shareholders. And finally, strong net debt portfolio growth of over $240 million, which excludes the portfolio growth of our private fund business. We are pleased that we were able to deliver record operating performance in Q4 and the full year, while at the same time managing the business quite conservatively with very low leverage and excess liquidity. We expect 2024 to be another year with higher-than-normal volatility and a higher-for-longer rate environment, but as we discussed on our last call, we expect the market environment for new originations to improve throughout 2024. We are already seeing this come to fruition in Q1, where we are benefiting from the balance sheet decisions that we made in 2023. Going forward, we will continue to take steps to manage our business and balance sheet defensively while maintaining maximum flexibility to shift to offense quickly and aggressively if deal quality warrants it, as we are doing in Q1. This includes continuing to enhance our strong liquidity position, maintaining low leverage, tightening our credit screens for new underwritings, and driving our first-lien exposure up, which reached 89% in Q4, our highest level since Q1 2017. Let me now recap some of the key highlights of our performance for Q4. In Q4, we generated record total investment income of $122.6 million, up 22% year-over-year and record net investment income of $86 million, up over 38% year-over-year, or $0.56 per share, providing 140% coverage of our base distribution of $0.40 per share. We were able to achieve 140% coverage of our base distribution despite ending the quarter with very conservative GAAP leverage of 87.1%. This is our third consecutive quarter of over $100 million of quarterly core income, which excludes the benefit of prepayment fees or fee accelerations from early repayments, and our fifth consecutive quarter of delivering record net investment income. We also generated a return on equity in Q4 of over 20% for the third consecutive quarter. Our portfolio generated a GAAP effective yield of 15.3% in Q4 and a core yield of 14.3%. Our balance sheet remains very well positioned to support our continued growth objectives and serves as a key differentiator of our business relative to others in the asset class. The focus of our origination efforts in Q4 was once again on quality and diversification. Our Q4 origination activity was driven by both our technology and life sciences teams delivering healthy funding performance during the quarter, although new business activity was again intentionally weighted slightly more towards life sciences companies. In Q4, approximately 57% of our fundings were to life sciences companies, while approximately 66% of our commitments during the quarter were to life sciences companies. This reflects our slightly more cautious view on the technology sector through year-end. We funded debt capital to 27 different companies in Q4, of which five were new borrower relationships. Consistent with what we have seen throughout the year, we expanded our funding relationship with numerous portfolio companies that continued to show strength and achieved performance milestones during the fourth quarter. In addition, the strong level of fundings to existing companies also helped to maintain our available unfunded commitments at approximately $335 million, which decreased from $400 million in Q3. As anticipated, our origination activity has begun to accelerate in Q1. Since the close of Q4 and as of February 13, 2024, our deal team has closed $551.8 million of new commitments, and we have funded $383.8 million. We have pending commitments of an additional $506.5 million in signed, non-binding term sheets. The bar for us on new originations remains very high, and we continue to pass on the vast majority of deals that we are currently seeing in the market. Many of the quality, later-stage deals that put off debt decisions in 2023 are now back at the table, and that is driving our very strong start to the year on originations. Having a strong balance sheet, staying power, and relationships that run wide and deep in the ecosystem gives us great confidence in our ability to continue to generate and deliver quality asset growth over the coming quarters. We believe that Hercules is best positioned in the asset class for continued and sustained success. Consistent with our historical approach to underwriting credit, we will remain disciplined on new originations and we will prioritize credit quality over chasing higher-risk transactions with a yield premium. Given the market backdrop throughout 2023, we are pleased with the exit activity that we saw in our portfolio during the year. In Q4, we had two additional portfolio companies complete acquisitions. For fiscal year 2023, we had one portfolio company complete their IPO and two additional portfolio companies file for IPOs, along with 17 portfolio companies completing M&A transactions. Our solid portfolio activity, despite the challenging, broader exit environment, continues to validate the great work and selective underwriting that our investment teams do. As we anticipated, early loan repayments increased in Q4 to approximately $278 million, which came in above our guidance of $150 million to $250 million. For Q1 2024, we expect prepayments to decrease from Q4 levels and be in the range of $125 million to $225 million, although this could change as we progress in the quarter. The credit quality of the debt investment portfolio remains stable. Our weighted average internal credit rating of 2.24 improved slightly from the 2.28 rating in Q3 and remains at the lower end of our normal historical range. Our Grade 1 and 2 credits improved to 62.6% compared to 62.1% in Q3. Grade 3 credits were slightly lower at 34% in Q3 versus 34.5% in Q3. Our rated four credits increased moderately to 3.4% from 2.6% in Q3, and we had no rated five credits in Q4. In Q4, the number of loans on nonaccrual decreased by one. We have one debt investment on nonaccrual with an investment cost and fair value of approximately $30.9 million and $0 million, respectively, or 1% and 0% as a percentage of the company's total investment portfolio at cost and value, respectively. As of our most recent reporting, 100% of our debt portfolio companies remain current on contractual payments to Hercules. Our workout efforts with regards to Convoy remain ongoing, and our recovery efforts will likely wrap up early this year, although that situation remains ongoing and fluid. With respect to our broader credit book and outlook, we generally remain pleased by what we are seeing on a portfolio level, and our monitoring remains enhanced given continued market volatility and uncertainty. Our focus on credit underwriting and a diversified asset base is continuing to serve us well. We are continuing to see general outperformance and positive momentum in terms of capital raising, M&A activity and milestone achievement throughout our life sciences book, while things continue to remain more muted on the technology side with respect to the same. During Q4 and throughout the year, we experienced many of the same themes that we have been discussing over the last several quarters. With so much attention paid to what the market has been describing as a VC winter, capital raising across our portfolio remained relatively strong, with over $1.1 billion raised in Q4. In total for the year, we had 58 portfolio companies raise approximately $6 billion in new capital, which was heavily weighted towards our life sciences portfolio. During Q4 2023, Hercules had net realized gains of $2.8 million, comprised of net realized gains of $4.6 million, primarily due to the gain on equity investments, offset by approximately $1.8 million due to the loss on debt and warrant investments. For 2023, we generated $8.4 million of realized gains. Our net asset value per share in Q4 was $11.43, an increase of 4.6% from Q3 2023. We ended Q4 with strong liquidity of nearly $750 million. Inclusive of available liquidity in our private funds, we have more than $1 billion of liquidity as of the end of Q4. Our balance sheet is both strong and stable, and it puts us in a strong position to be able to benefit from a new business environment that we anticipate will get better throughout 2024. Venture capital ecosystem fundraising and investment activity finished 2023 with fundraising activity at approximately $67 billion and investment activity at approximately $171 billion according to data gathered by PitchBook-NVCA. To put that into perspective, investment activity equaled 2020 levels in both dollars invested and number of companies raising capital at over 13,000 companies. Fundraising for the year exceeded 2019 levels. However, we expect fundraising to stay at the current level for the foreseeable future. We do not expect investment activity to reach the levels that we saw during the COVID pandemic near term, but we do expect investment activity to remain at healthy levels with more selectivity in terms of the profile of the companies that are receiving equity funding. With our record operating performance in 2023, we exited Q4 with undistributed earnings spillover of over $125 million or $0.80 per ending share outstanding. We are also very pleased to announce that our RIA has delivered its first distribution to HTGC shareholders. For Q4, we are maintaining our base distribution of $0.40 and we declared a new supplemental of $0.32 for 2024 which will be distributed equally over the next four quarters or $0.08 per share per quarter for a total of $0.48 of shareholder distributions. This is our fourth consecutive year of being able to provide our shareholders with a supplemental distribution on top of our regular quarterly base distribution. In closing, 2024 marks our 20th year investing in the venture and growth stage asset class, which is another milestone for our company. Our scale, institutionalized lending platform and our ability to capitalize on a rapidly changing competitive and macro environment continues to drive our business forward and our operating performance to record levels. Our success since inception over 20 years ago is attributable to the tremendous dedication, efforts and capabilities of our employees and the trust that our venture capital and private equity partners place with us every day. We are thankful to the many companies, management teams and investors that continue to make Hercules their partner of choice. I will now turn the call over to Seth.

Thank you, Scott, and good afternoon, everyone. As Scott noted, this quarter has been a record one for Hercules Capital, concluding a record-breaking 2023. Alongside historic investment activity this year, we achieved record quarterly and annual results in various areas, including total investment income, net investment income, and core income, all while carefully managing our balance sheet with low leverage and strong liquidity. We validated the advantages of scale in 2023 by achieving significant operating leverage as we increased our assets under management to record levels, allowing us to post a net investment income margin of 70.2% in Q4, the highest we've ever reached. Throughout 2023, our weighted average cost of debt remained under 5%, and we maintained conservative leverage, positioning us favorably compared to others in our asset class. This was made possible by proactively enhancing our balance sheet and liquidity early in the year, including renewing our $400 million credit facility with MUFG and establishing a new $175 million committed letter of credit facility with SMBC to manage our unfunded commitments more efficiently. We also bolstered liquidity by raising $108 million net of fees through an equity offering in August and an additional $230 million throughout the year via our ATM program. We began 2024 with nearly $750 million in available liquidity, a net regulatory leverage of about 72%, and we have received our fourth green light letter from the SBA, providing an extra $175 million of regulatory exempt leverage along with a minor private placement maturity of $105 million in July. This positions us well to invest in the strong pipeline Scott discussed and to strategically tap the market for additional liquidity to support our business needs if necessary. With this in mind, let's examine these areas: the income statement, performance highlights, NAV activity, leverage and liquidity, and our financial outlook. First, regarding the income statement performance and highlights for Q4, total investment income was $122.6 million, an increase over the previous quarter, driven by growth in our debt portfolio and a modest rise from a $1.4 million dividend from our wholly-owned RIA. Core investment income, which is a non-GAAP measure, surpassed $100 million at $114.5 million, excluding benefits from loan prepayments. Net investment income reached another record at $86 million, a 12% increase quarter-over-quarter or $0.56 per share in Q4. The NII margin was 70.2% for Q4, rising every quarter since Q1 2022. Our effective and core yields changed slightly to 15.3% and 14.3%, respectively, compared to 15.5% and 14.2% in the prior quarter, with the decline in effective yield attributed to lower fees from prepayments this quarter. Regarding expenses, our gross operating expenses dropped to $38.2 million from $42.4 million in the previous quarter due to lower compensation accruals. After accounting for costs recharged to the RIA, our net operating expenses declined to $36.6 million. Interest expense and fees rose modestly to $19.9 million compared to $19 million in the earlier quarter due to higher utilization of credit facilities. Our SG&A decreased to $18.2 million, below my guidance of $21 million to $22 million, thanks to reduced compensation accruals. After accounting for costs recharged to the RIA, SG&A expenses were $16.6 million. Our weighted average cost of debt was 4.9%, a slight increase over the previous quarter reflecting higher credit facility use. Our ROAE, or net investment income over average equity, rose another 110 basis points to 21.3% for Q4, while our ROAA, or NII over average total assets, stood at 10.6%. Moving to NAV unrealized and realized activity, our NAV increased by $0.50 per share to $11.43, reflecting a 4.6% quarter-over-quarter rise. This increase was driven by the record net investment income of $86 million, unrealized appreciation of $31.3 million, including a reversal of prior unrealized depreciation of $9.9 million, net realized gains primarily from equity sales totaling $2.8 million, and accretion from the use of our ATM, all surpassing the dividends paid this quarter. The $31.3 million unrealized appreciation was mainly from $9.2 million in net unrealized appreciation on the loan portfolio and $12 million on our public equity and warrant portfolio. Regarding leverage and liquidity, our GAAP and regulatory leverage dropped to 87.1% and 77.4%, respectively, compared to the prior quarter due to the equity raised via our ATM. After netting leverage against cash on the balance sheet, our net GAAP and regulatory leverage stood at 81.6% and 71.9%, respectively. We concluded the quarter with nearly $750 million in available liquidity, excluding capital raised by our funds managed by our wholly-owned registered investment advisor subsidiary. Including these amounts, the Hercules platform had over $1 billion in available liquidity at year-end. This strong liquidity places us in an excellent position to support our current portfolio companies and seek new opportunities. Additionally, we continued to tap the ATM market opportunistically during the quarter, raising about $100 million, which resulted in a $0.16 per share increase to NAV. For the year, we raised around $230 million through the ATM program. Looking forward to the first quarter, we are maintaining our core yield guidance range of 13.8% to 14%, not accounting for any future benchmark interest changes. It’s important to note that approximately 95% of our portfolio is floating with a floor, meaning that any decreases in Fed interest rates may not proportionately lower our core yield. While predicting this is challenging, we anticipate $125 million to $225 million in prepayment activity in the first quarter. We expect our interest expenses for Q1 to remain stable compared to the prior quarter. For this first quarter, we project SG&A expenses in the range of $25.5 million to $26.5 million, along with an RIA expense allocation of about $2.5 million to $3 million. Keep in mind that the first quarter usually incurs higher payroll taxes and benefits expenses. As previously indicated, the advisor business initiated dividend payments to Hercules Capital in Q4, and going forward, we expect a quarterly dividend from the RIA of roughly $1 million to $1.5 million. In conclusion, as we reflect on the record accomplishments of 2023, we remain optimistic about 2024 and our capacity to continue fostering growth across the platform while prioritizing delivery and top-tier shareholder returns. I will now hand the call over to the operator to start the Q&A session.

Our first question comes from Brian McKenna of Citizen JMP. Your line is open.

Okay, great, thanks. Good evening, everyone. So just a question on the dividend to start. It's clearly a record quarter of results, and as you noted, dividend coverage on a core basis totaled 140%. So, it would seem like the starting point for earnings in 2024 is quite a bit higher than the base dividend you announced yesterday. So, could you just walk us through the rationale about maintaining and not increasing the current base dividend?

Sure. Thanks, Brian. I think we've been pretty consistent over the course of the last several years in terms of how we manage the base distribution. We never want to set the base distribution at a number that we think would jeopardize our ability to maintain it irrespective of market and rate environment conditions. We set the base distribution based on our outlook for core income, where we essentially back out the benefit of any prepayments and accelerations. And right now, we want to continue to take a conservative position. That was the choice that we made with respect to Q4. We are continuing to deliver that outperformance to our shareholders via the supplemental distributions. This is the fourth consecutive year where we've been able to enhance the quarterly base distribution with an additional supplemental distribution. And we think that that's the right way to operate the business in the current environment. It certainly does not mean that that's not going to change on a go-forward basis. But that was the rationale for the decision to maintain $0.40 and declare a $0.32 supplemental distribution payable $0.08 per quarter in 2024.

Got it. Helpful. And then maybe just a bigger picture question for you, Scott. You know, so you noted Hercules has been operating the business for 20 years now. You've clearly seen a lot of evolution across the industry over this time, but when you think about the next five years or ten years plus, how do you see the sector evolving from here? And then what are you doing at Hercules today to make sure you're positioning the firm for this change over time?

Yeah. Thanks for the question, Brian. Yeah, I think when you look back over 20 years, it's a long period of time, and while that performance for us has been incredibly impressive, I think what's most unique about Hercules is how optimistic the team and I are about what the next five years to ten years look like, despite the tremendous success that we've had. Our firm has grown exponentially. We've maintained a very strong culture. We have always, since inception, operated the firm with a focus on serving our clients and the venture ecosystem exclusively. There are a number of opportunities in terms of platform expansion that we expect to continue to play out over the coming years. Over the last two years to three years, you've seen us rapidly build and grow our private funds business, and we really think that this is just the beginning of the next level of evolution for us as an operating company.

All right, great. I'll leave it there. And congrats on another great quarter.

Thanks, Brian.

Thank you. One moment, please. Our next question comes from the line of Crispin Love of Piper Sandler. Your line is open.

Thank you. Good afternoon. First, regarding fundings, they were somewhat weaker in the fourth quarter compared to previous quarters, but commitments for the first quarter of 2024 are very promising. What do you think are the main changes from late 2023 to the first quarter so far? Is it primarily a matter of timing? Also, looking ahead to the year, do you think fundings in 2024 will increase compared to the $1.6 billion achieved in 2023?

Sure. Thanks, Crispin. There are a few points to mention. One advantage of being an internally managed BDC is that we are not compelled to pursue deals that do not meet our criteria. In the fourth quarter, we experienced significant deal flow, but much of it did not align with our underwriting standards, leading us to adopt a more cautious approach. Nevertheless, we had a strong quarter in Q4 with $413 million in commitments and funded $307 million. We successfully financed some excellent new companies and expanded our existing funding relationships with several portfolio companies that are exceeding our expectations. Starting in Q3 of last year, we provided clear indications that we anticipated an improvement in the new deal environment for 2024, based on discussions our teams were having with companies in the market. Given the typical fundraising cycle for these companies, we expected to see a significant influx of high-quality late-stage companies entering the market in early 2024, and that is indeed what has occurred so far. You mentioned the pipeline, which is currently the strongest it has ever been, both in terms of closed and signed commitments for the quarter. As of February 13, our team has already closed $552 million in commitments, with an additional $500 million-plus in signed, non-binding commitments. We are optimistic about our funding trajectory moving forward. While we do not provide full-year guidance on funding numbers, if we maintain the current momentum as the year begins, we expect to surpass the $1.6 billion we reached last year.

Thanks, Scott. That all makes sense. And then just on expenses. Seth, as you said, you came in below the SG&A guide, looks to be primarily driven by lower compensation and benefits expenses. I think that line was down over 30% sequentially. You mentioned that it was due to lower variable compensation, but what was the reason there just given the strong results? And what does that mean for that line as you start 2024? Should there be a pretty big jump there in the first quarter?

Yeah, and that's why it guided higher, Crispin. So, you hit the right punchline that we would expect a reversion back to normal. But it was based on the lower funding volume in Q4, and that's what really drove the variable compensation portion of the accrual. It's that simple.

Okay, sounds good. Thank you, and appreciate you taking my questions.

Thanks, Crispin.

One moment, please. Our next question comes from the line of Christopher Nolan of Ladenburg Thalmann. Your line is open.

Hey, guys. Hey, Seth, the RIA dividend of $1 to $1.5 is that quarterly or annual?

That's quarterly. Good question. Yeah, I should have emphasized that. Thanks, Chris.

Regarding the previous question about dividends, your excise tax appears to be increasing annually. Could we expect a supplemental dividend in addition to the one you've just announced to help manage the excise tax expense while keeping the base dividend stable?

Yeah, well, it's two-dimensional. One, we keep the base dividend at a level that we believe is sustainable through an entire interest rate cycle. Two, we do distribute an additional supplemental level to make sure that we are keeping the excise tax in check, but also the requirement as a registered investment company that we need to distribute 90% of our income. So, we're balancing all those dimensions out, making sure that we're returning the income to the shareholders, retaining what we can and should for building out the infrastructure and the structure for future investment, but it is a balancing act between those, and the excise tax would naturally go up as our income levels go up. So, the small amount that we're retaining is certainly going to attract a higher amount of nominal tax at a 4% rate.

Got you. And then I guess a final, broader question. Following the demise of SVB, I presume more of your portfolio companies are banking at a broader array of banks. Given the threat posed to that sector by commercial real estate, how do your investment loans look and what portion of your portfolio companies have a bank facility ahead of your loans?

Hey, Chris, a couple of things there. First, I would not characterize it as the demise of SVB. It was certainly the demise of SVB, as we all once knew the firm. But the firm is continuing to operate under the First Citizen's umbrella. We continue to see them in the market from time to time. We've done a handful of transactions with them, and so the firm didn't, all of a sudden, in March of last year, just go away. Obviously, they're rebranded and the team has changed quite a bit, but we are still seeing them in the market. We made the comment in the prepared remarks about our first-lien exposure. That first-lien exposure has been moving up steadily throughout 2023, and we ended the year at about 89%, which is the highest we've had since 2017. That gives you a pretty good indication of a couple of things. Number one, we are managing the business more conservatively, and we're focusing in on first-lien exposure. And number two, banks in general are just being a little bit less active. So, we're able to get more deals done alone than historically we have been able to, and so that really speaks to both of those points at the same time.

Okay, thanks, Scott.

Thanks, Chris.

Thank you. One moment, please. Our next question comes from the line of Ryan Lynch of KBW. Your line is open.

Good afternoon. I wanted to revisit some of your earlier comments about the level of activity you've seen in 2024, which has been quite remarkable. In 2023, your total gross debt and equity commitments were $2.2 billion. However, in just the first 45 days of 2024, your closed and pending investments amount to $1.1 billion, which is half of what you achieved in all of 2023. You mentioned some reasons for this increase, but I’m curious if there is also a change in the size of the average positions you're considering. Are you targeting larger businesses and companies in this market? Is that contributing to the significant rise in commitments, or is it simply a result of more activity and higher quality opportunities in 2024?

Sure. Thanks, Ryan. A couple of things there. First, I just want to point out the $1.1 billion is not just through 45 days. Right? $551 million of that has actually closed through the first 45 days, and then that next $500 million is signed as of the 45th day. So, we would expect that that $505 million, which is signed, if it gets through our diligence process to, you know, sort of get to the closing side of things over the next 30 days to 60 days. So, don't think of that $1.1 billion as something that we've done in 45 days. I would think of it as something that we would expect to do over the first 90 days to 115 days of the year. So, still incredibly impressive. But I just wanted to point that out. In terms of the second part of the question, it's primarily just based on activity. There is certainly a component of, we are looking at, as we've signaled the last several quarters, larger, more scaled, more stable businesses. That is an intentional shift that we've made. We continue to be of the view that a lot of the smaller companies that received financing historically are going to struggle to receive equity support on a go-forward basis. So, when we think about things from a risk-adjusted return perspective, we want to focus right now and we're going to continue to focus on larger, more scaled, more stable businesses. And we think that that's the best thing to do for our shareholders long term. If you look at it in terms of average dollars per deal, the numbers are up slightly, but it's not really materially increased from where it was throughout 2023.

Okay, understood. And then on the guidance you gave regarding the advisor, I think you said and correct me if I'm wrong, $2.5 million to $3 million of RAA expense reductions and then $1 million to $1.5 million from the RIA for dividend. So, that's $3 million to $4.5 million of total value that's going to come back to the BDC from either expense reductions or dividends. That's a pretty big jump from certainly what you were doing in kind of the beginning of 2023 and even from the most recent, this fourth quarter, in just total value that the RIA is generating. Can you talk about what's really driving that sizable increase in value coming back to BDC shareholders recently?

Sure. Thanks, Ryan. So, $2.5 million to $3 million is not actually outside of the scope of what we've been doing on a per-quarter basis. We had a little bit lower allocation on the fact that our total SG&A costs went down in the fourth quarter, as discussed previously on the variable comp accruals. And so, there's nothing abnormal about that, although the portfolio does continue to grow, that we're managing in the private funds, and therefore, it absolutely is driven and connected to that. Originations are the biggest portion of our expense allocation on a per-quarter basis. So, the variable comp that is associated with originating new deals is something that also gets tacked and allocated to those deals that are allocated or originated by the RAA managed funds. So, there's a direct relationship there. What comes up and is new is this a $1 million to a $1.5 million per quarter of the dividend flow coming into Hercules Capital, the BDC, and then ultimately to our shareholders that we had guided from the very beginning that this would eventually come as soon as the RIA managed to overcome the original establishment costs, as it was getting started and generating enough of a carry and a management fee to start paying the dividend to the BDC. So absolutely in line with what the original guidance is. It just looks like a lot right now because we had a lower allocation in Q4, and these are the initial dividend flows that are occurring.

Okay, makes sense. I appreciate the time this afternoon and really great quarter, guys.

Thanks, Ryan.

Thank you. One moment, please. Our next question comes from the line of John Hecht with Jefferies. Your line is open.

Hey, guys, thanks for taking my questions and congrats. First question is, you've grown a lot. You've got very, very low nonperforming assets. And your leverage is, in the context of your targets, pretty low. I'm just wondering for this year, should we think about some sort of desire to increase leverage, or how do we think about your target leverage ratios as you grow this year?

Thanks for the question, John. No change in terms of our guidance for leverage. You've been following us for a long time, so you'll appreciate the comment. We've always sort of run the balance sheet conservatively. Right now, we're running it conservatively, and we're taking a defensive posture. So, we're running it at even lower leverage than we typically do. I think our expectation is, given our funding goals for 2024, that leverage will increase slowly throughout the year, but we would expect to continue to manage the business from a balance sheet perspective conservatively, with low leverage and long liquidity.

Okay. And then maybe can you talk about LTV and spreads on recent transactions and how that, you know, maybe has changed over the course of the last few months?

Sure. LTV is pretty consistent with our historical underwriting. The range for us, if you look at our publicly reported data over the last several years, has been on the very low end 5%, on the very high end 20%. The majority of deals that we're doing currently are in that sort of low teens from an LTV perspective. And I think that's what we're going to continue to target short to medium term here. And then in terms of spreads, you know, we're not seeing a lot of pressure right now on spreads. Seth just updated our guidance in terms of core yield. We expect to continue to be in that very high 13%, low 14% from a core yield perspective, and we've done a great job or Seth's done a great job in terms of managing the liability side of the balance sheet to maintain those spreads, which have continued to increase over the last several years as the rate environment has improved in our favor.

Great. Thanks very much, guys. All my other questions have been answered.

Thanks, John.

Thank you. I'm showing no further questions at this time. Let's just turn the call back over to Scott Bluestein, CEO, for any closing remarks.

Thank you, Valerie. And thanks to everyone for joining our call today. As a final note, we will be participating in the UBS Financial Services Conference from February 26 to February 29 in Miami. If you are interested in meeting with us at this event, please contact UBS directly or Michael Hara. We look forward to reporting our progress on our Q1 2024 earnings call. Thanks, everybody.

Thank you. Ladies and gentlemen, this does conclude today's conference. Thank you all for participating. You may now disconnect. Have a great day.